NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update

CompletedN/A

Sponsor: Sanofi Pasteur, a Sanofi Company

Conditions: Dengue Virus Infection

Interventions: No intervention

Countries: France

The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material. The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

\- Healthcare professionals who are current or past prescribers of Dengvaxia

Exclusion criteria:

* Healthcare professionals who have never prescribed Dengvaxia
* Healthcare professionals who may have a conflict of interest with the survey (i.e. Healthcare professionals employed by regulatory bodies, pharmaceutical industries)
* Healthcare professionales who have participated in testing the questionnaire for comprehensibility, consistency and the appropriateness of medical terms

The above information is not intended to contain all considerations relevant to participation in the survey.

Locations (1)

La Defense, France